Share Price slow to react on PPS announcement. Not unusual though.
My thoughts for the results: Tough one to delve into but overall a very positive sign for the coming year. Just ignore all the one-off costs incurred last FY.
The Bad:
If you're solely looking at Net Income, then it decreased approx 12% to 688,000 for the year
Cash on Hand down from $10.4M to $9M (still pretty impressive considering everything that happened over the year)
The Good:
Funds Under Administration (FUA) soaring to $6.1 Billion
Customer growth both locally & internationally
EBITDA up 54% to 6.3 million (revenue starting to considerably outstrip operating expenses)
Most of the costs involved in FY16-17 were attributable to one off payments like:
- Restructure cost about $1M
- acquisitions of around $700K
- 95% increase in income tax costs this year compared to last year
- Moving building costs
- Legal costs for management fiasco
No Debt
No increase in IT Costs/Support
Increase in Sales / Marketing costs
Overall:
Think the staff have done an incredible job of maintaining a positive outcome among so much uncertainty. Numbers look like the company has now got a solid suite of products & is going to invest heavily in sales/marketing in FY17-18 to try to further raise the FUA. Which should in turn, further increase the gap between revenue & operating expenses.
I think if they have another year like the last without all the one-off costs the numbers will look staggeringly good.
DYOR
- Forums
- ASX - By Stock
- News: PPS Praemium says FY net profit attributable to members $46,967, up 132.5 pct
Share Price slow to react on PPS announcement. Not unusual...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PPS (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $250.6M |
Open | High | Low | Value | Volume |
67.0¢ | 67.0¢ | 65.5¢ | $89.39K | 135.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 19917 | 65.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
66.0¢ | 21990 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7000 | 0.590 |
1 | 52000 | 0.575 |
6 | 111190 | 0.570 |
2 | 35080 | 0.565 |
5 | 50580 | 0.560 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 131318 | 9 |
0.605 | 48960 | 3 |
0.610 | 44045 | 4 |
0.615 | 78993 | 6 |
0.620 | 110891 | 5 |
Last trade - 12.44pm 25/11/2024 (20 minute delay) ? |
Featured News
PPS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online